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Abstract
Background: Neonatal meningitis-causing Escherichia coli (NMEC) is the predominant Gram-negative bacterial pathogen
associated with meningitis in newborn infants. High levels of heterogeneity and diversity have been observed in the
repertoire of virulence traits and other characteristics among strains of NMEC making it difficult to define the NMEC
pathotype. The objective of the present study was to identify genotypic and phenotypic characteristics of NMEC that can
be used to distinguish them from commensal E. coli.
Methods: A total of 53 isolates of NMEC obtained from neonates with meningitis and 48 isolates of fecal E. coli obtained
from healthy individuals (HFEC) were comparatively evaluated using five phenotypic (serotyping, serum bactericidal
assay, biofilm assay, antimicorbial susceptibility testing, and in vitro cell invasion assay) and three genotypic
(phylogrouping, virulence genotyping, and pulsed-field gel electrophoresis) methods.
Results: A majority (67.92 %) of NMEC belonged to B2 phylogenetic group whereas 59 % of HFEC belonged
to groups A and D. Serotyping revealed that the most common O and H types present in NMEC tested were
O1 (15 %), O8 (11.3 %), O18 (13.2 %), and H7 (25.3 %). In contrast, none of the HFEC tested belonged to O1 or O18
serogroups. The most common serogroup identified in HFEC was O8 (6.25 %). The virulence genotyping reflected that
more than 70 % of NMEC carried kpsII, K1, neuC, iucC, sitA, and vat genes with only less than 27 % of HFEC possessing
these genes. All NMEC and 79 % of HFEC tested were able to invade human cerebral microvascular endothelial cells.
No statistically significant difference was observed in the serum resistance phenotype between NMEC and
HFEC. The NMEC strains demonstrated a greater ability to form biofilms in Luria Bertani broth medium than
did HFEC (79.2 % vs 39.9 %).
Conclusion: The results of our study demonstrated that virulence genotyping and phylogrouping may assist
in defining the potential NMEC pathotype.
Keywords: Biofilms, Escherichia coli, Genotyping, Invasion assay, Neonatal meningitis, Serotyping, Virulence
Background
Escherichia coli is a versatile bacterial species that exists as
a commensal in the lower gastrointestinal tract of humans
and animals as well as a pathogen that causes a variety of
diseases [1, 2]. Unlike commensal E. coli, pathogenic E.
coli harbor various virulence genes which provide the
basis for categorizing them into different pathovars with
each pathovar having the ability to establish a distinct
infection [1]. These virulence traits include adhesins, iron
acquisition systems, toxins, invasins, and serum resistant
components of the cell wall that are encoded by the bac-
terial chromosome and plasmids [1–6].
A distinct pathotype of extra-intestinal pathogenic E. coli
(ExPEC) known as neonatal meningitis-causing E. coli
(NMEC) have the ability to survive in blood and invade
meninges of infants to cause meningitis [1, 7, 8]. Escheri-
chia coli associated neonatal meningitis is one of the most
common infections that accounts for high mortality and
morbidity rates (10–30 %) during the neonatal period [1, 9].
Although distinct sets of virulence traits have been identi-
fied in diarrheagenic E. coli and other ExPEC pathovars,
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distinct virulence traits have not been identified to define
the NMEC pathotype [10]. Several studies have attempted
to characterize NMEC strains using phenotypic and geno-
typing methods, such as serotyping, multi-locus sequence
typing (MLST), phylogrouping, pulsed-field gel electro-
phoresis (PFGE), antibiotic resistance gene profiling, and
virulence genotyping [7, 10–13]. A recent study showed
that NMEC strains are diverse in their virulence gene
repertoire and the genes that are uniquely associated
with NMEC have yet to be identified [10]. Although
NMEC have to breach the blood brain barrier (BBB)
to reach and infect the meninges, the studies that
used various genotypic and phenotypic traits to
characterize NMEC have not compared the ability of
different NMEC strains to invade the BBB using a
model comparable to human brain microvascular
endothelial cells. Here, we attempted to determine the
genotypic and phenotypic characteristics of NMEC
including their ability to invade the BBB and identify
a set of virulence genes that were relatively common
in NMEC as compared to fecal E. coli from healthy
humans (HFEC).
Results
Phylogenetic typing of NMEC and HFEC
All four major phylogenetic lineages (A, B1, B2, and D)
were represented by both NMEC and HFEC although
the distribution of each lineage among the isolates be-
longing to two sources (i.e. NMEC and HFEC) (Table 1,
Additional file 1: Table S1) was different. Phylogroup B2
was overly represented in NMEC (67.92 %) as compared
to HFEC (29.17 %) (p < 0.0001) whereas the phylogroups
A and B1 were more common in HFEC (31.25 % and
12.5 %, respectively) than in NMEC (9.43 % and 3.77 %,
respectively) (p = 0.0001 and p = 0.0225, respectively). No
statistical difference was observed for the distribution of
group D between NMEC and HFEC (p = 0.2395).
Serotyping
Serotyping of NMEC and HFEC isolates (Fig. 1 and
Table 2) showed that 18 different O serogroups were
present in NMEC while 19 different O groups were ob-
served in HFEC. Three isolates of NMEC and six isolates
of HFEC were not typeable by the O antisera used in the
study. Another four NMEC and two HFEC demonstrated
multiple O antigen types. The most common O types
present in NMEC were O1 (n = 9), O8 (n = 6), and
O18 (n = 7) whereas O20 (n = 8) and O148 (n = 5) were
more common in HFEC than the other O types. Similarly,
among NMEC strains tested, ten different H types were
observed, H7 being the most prevalent (n = 24). HFEC
strains belonged to 19 different H types with nine isolates
demonstrating an H- negative phenotype.
Serum resistance
No statistically significant difference in the percentages
of serum resistant isolates between NMEC and HFEC
(91.82 ± 2.17 and 90.97 ± 1.2, respectively) was observed
(p =0.5172).
Virulence genotyping
The number of virulence traits present in NMEC was
higher (13 ± 3.84) than in HFEC (5.50 ± 2.49) revealing a
considerable variation between the virulence gene pro-
files of E. coli from two different sources (Additional file
1: Table S1). For example, of the 26 VFs examined in the
study, the occurrence of 21 genes was significantly
higher (p <0.05) in NMEC than in HFEC (Fig. 2 and
Table 3). Notably, K1 capsular type, sfa/foc, sat, hlyA/D,
iutA, papG III, and afa genes were only represented in
NMEC populations, although their occurrence among
NMEC isolates was low except for the K1 capsular type.
Virulence traits kpsII, sitA, neuC, iucC, and vat were
more commonly associated with NMEC than with HFEC
(prevalence >70 % and representation >2-folds higher in
NMEC than in HFEC). Similar to the observations made
by previous studies, some virulence genes that were im-
plicated in the penetration of BBB, such as fimH, npl,
and ibeB were equally present in both NMEC and HFEC
strains [10]. On the other hand, some virulence genes,
such as cnf1 and traJ, that were considered to be
required for NMEC pathogenesis, were possessed only
by a minority of NMEC (cnf1 and traJ in 27.45 % and
43.40 % of NMEC, respectively). However, these genes
were more frequently observed in NMEC than in HFEC
(Table 3).
PFGE
Out of the NMEC and HFEC isolates tested, only 98
were typeable by PFGE. The HFEC strain 17 and two
NMEC isolates (14 and 20) were nontypeable with
XbaI restriction digestion. The typeable isolates dem-
onstrated 86 distinct PFGE fingerprint patterns or
pulsotypes (Fig. 1). Of the 86 pulsotypes, 79 were
unique and each pattern was present only in one iso-
late. The other seven pulsotypes were present in two
or more isolates of E. coli. Not a single pulsotype was
shared between NMEC and HFEC.
Table 1 Distribution of different phylogroups between neonatal
meningitis E. coli (NMEC) and fecal E. coli from healthy individuals
(HFEC). A p <0.05 reflects a statistical significance
Strains Phylogroup (%)
A B1 B2 D
NMEC 9.43 3.77 67.92 18.87
HFEC 31.25 12.5 29.17 27.08
p value 0.001 0.0225 <0.001 0.2359
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Fig. 1 Characteristics of neonatal meningitis E. coli (NMEC) and fecal E. coli from healthy individuals (HFEC) used in the study
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Biofilm assay
The ability to form biofilms on a microtitre plate by NMEC
and HFEC were assessed using M9 minimal medium sup-
plemented with niacin and Luria Bertani (LB) broth (Add-
itional file 1: Table S1). About 53 % of NMEC strains
cultured in M9 minimal medium were able to form bio-
films on microtitre plates whereas only 39.9 % of HFEC
possessed this phenotype (Fig. 1). However, this difference
was not statistically significant (p = 1.000). A higher per-
centage of NMEC (79.2 %) formed biofilms when they were
cultured in LB broth than in the M9 medium (52.8 %) but
the ability to form biofilms by HEFC remained the same
regardless of the medium used.
Antibiotic susceptibility testing and multilocus sequence
typing (MLST)
As depicted in Table 4, a majority of NMEC and HFEC
were susceptible to most of the antimicrobials tested in the
study. All isolates tested were susceptible to gentamicin,
imipenam, meropenem, piperacillin/tazobactam and amika-
cin. Only five isolates of NMEC and three isolates of HFEC
were resistant to all four third generation cephalosporins
(cefotaxime, cefpodooxime, ceftazidine and ceftrixone). The
minimal inhibitory concentration (MIC) values for these
eight isolates were increased by ≥3 folds when cefotaxime
and ceftazidine were used in combination with clavulanic
acid as compared to the MIC values for cefotaxime and
ceftazidine alone confirming that these isolates possessed
the ESBL resistance phenotype according to the Clinical
Laboratory Standards Institute (CLSI) guidelines. To fur-
ther characterize E. coli demonstrating an ESBL phenotype,
they were subjected to MLST. The eight isolates with an
ESBL phenotype fell into eight different sequence types
(STs) demonstrating a clonal diversity among the isolates
(Table 5).
In-vitro cell invasion assay
Invasion frequencies between NMEC and HFEC (85.31
± 10.60 vs 54.04 ± 7.0387, respectively; p = 0.0196) dis-
played a statistically significant difference (Fig. 3). Except
ten isolates of HEFC, all other HFEC and NMEC isolates
were able to invade human cerebral microvascular
endothelial cells (hCMECs) albeit at different invasion
frequencies (Additional file 1: Table S1). Some HFEC
strains demonstrated invasion frequencies similar to
or higher than that of the prototypic NMEC strain
RS218.
Table 2 Distribution of O and H antigen types among NMEC and HFEC strains
NMEC HFEC
O Type No. of Isolates H Type No. of Isolates O Type No. of Isolates H Type No. of Isolates
1 9 1 4 7 4 4 1
2 3 4 6 8 3 5 2
5 1 5 4 9 2 7 5
6 2 7 24 10 1 8 2
7 2 9 1 20 8 11 2
8 6 10 1 36 1 12 1
11 1 18 1 38 1 15 3
15 1 19 3 46 1 18 1
16 2 27 1 68 3 19 1
18 7 6/41 6 73 1 21 1
19 1 POS 2 104 2 34 1
21 1 117 1 39 1
25 2 137 1 42 1
75 3 146 1 49 1
78 1 148 5 53 1
92 1 153 1 6/41 1
107 1 167 2 40/44 1
12/16 2 178 1 NEG 9
M 4 91/167 2 POS 13
NEG 3 M 1
NEG 6
M multiple O types, POS positive fliC PCR amplification but untypeable, NEG negative (no agglutination with O antisera or no fliC PCR amplification)
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Discussion
Pathogenic E. coli consist of diarrheagenic E. coli causing
intestinal disease and ExPEC causing extraintestinal
diseases in humans and animals [1, 2]. Both diarrhea-
genic E. coli and ExPEC are grouped into many patho-
types or pathovars depending on the clinical outcome
of the disease and virulence properties of E. coli in-
volved [1, 11, 14]. Of these two major groups of patho-
genic E. coli, ExPEC possess the ability to colonize and
infect extraintestinal sites of the host by means of
horizontally acquired genetic determinants or virulence
genes [14]. Several studies have been conducted to identify
the unique virulence traits of ExPEC, such as uropatho-
genic E. coli, NMEC, and avian pathogenic E. coli to under-
stand the genetic makeup and pathogenic potential of
different ExPEC pathovars [10–13]. However, these studies
indicate that substantial genotypic and phenotypic het-
erogeneity exist within each pathotype, and a pathotype
cannot be defined merely based on the presence of a
defined set of virulence genes or characteristics. Never-
theless, some virulence attributes are shared among differ-
ent pathotypes making it difficult to delineate ExPEC
pathotypes [7, 10, 12, 13, 15]. Here, we comparatively ana-
lyzed genotypic and phenotypic traits of NMEC and HFEC
to identify the characteristics that would assist in defining
the NMEC pathotype.
In this study, we examined a collection of NMEC for
the most prevalent (>70 % of the NMEC population)
and overly represented virulence traits found in NMEC
as compared to HFEC (>3-fold) for defining the NMEC
Fig. 2 Heat map demostrating the distribution of virulence genes in NMEC and HFEC. Red represents the presence and black represents the absence
of a virulence gene; a, virulence genes equally present in both NMEC and HFEC; b, virulence genes are more prevalent and overly represented in
NMEC than in HFEC; c, virulence genes are less prevalent in both NMEC and HFEC
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pathotype. Based on these criteria, we have identified six
genes, namely, kpsII, K1, neuC, iucC, sitA, and vat, which
were predominantly associated with NMEC pathotype.
Among these, some virulence traits such as, kpsII, sitA,
and vat are considered as typical traits of NMEC [10].
None of the HFEC isolates surveyed possessed all six
genes, whereas 40 % of NMEC isolates harbored all six
genes suggesting that these genes might be used to
predict the NMEC pathotype (Fig. 4). As depicted in
Fig. 4, a majority of NMEC possessed the K1 capsular type
(n = 76 %). All K1+ NMEC were positive for sitA together
with vat and/or iucC. Except three isolates, all other K1+
NMEC harbored the neuC gene as well. Taken together,
these results suggest that a typical NMEC might be de-
scribed as K1+ and sitA+ and having at least two of the
other three genes; vat, neuC and iucC. Using this criterion,
it was possible to designate 74 % of NMEC used in this
study as typical NMEC whereas none of the HFEC satis-
fied these benchmarks. However, typing of a larger
collection of NMEC isolates representing different geo-
graphical regions might be required to confirm these
observations.
A PCR-based phylogrouping has been established to
determine the clonality within E. coli pathotypes [16, 17].
Previous studies have identified group B2 as the most com-
mon phylogroup of ExPEC suggesting that phylogrouping
may be used as a rapid typing method to identify potential
ExPEC [10, 12, 14, 18]. In the present study, we observed
that 67.9 % of NMEC fell into B2 phylogroup as compared
to 29.2 % of HFEC tested in the study. Phylogroups A and
B1 were more commonly associated with HFEC than with
NMEC. The virulence gene profiles of NMEC strains
belonging to each phylogroup lineage exhibited a higher
prevalence of virulence genes as compared to HFEC
strains belonging to the corresponding lineage (Table 6).
Taken together, our observations emphasize that phylo-
grouping alone is not suitable for predicting potential
NMEC.
Pulsotyping and serotyping have been used in various
studies to identify pathogenic clones and to distinguish
between pathogenic and nonpathogenic strains of many
bacterial species [7, 19, 20]. In our study, we observed a
considerable heterogeneity among both NMEC and HFEC.
As depicted in Table 2, despite this diversity, many NMEC
strains belonged to O1, O8, and O18 serogroups and H7
flagellar antigen type. Similar to our observation, previous
studies have also noted that the H7 antigen is present in
major virulent clones of ExPEC pathotypes making it a po-
tential target for future diagnostic and therapeutic inter-
ventions [21, 22]. Two subtypes of H7 antigen have been
identified for enterohemorrhagic E. coli (EHEC) based on
the flicC (H7) allelic polymorphism, a technique which
possibly can be used to type EHEC [23, 24]. For example,
H7a and H7c subtypes have been identified in E. coli O157:
H7 irrespective of their geographical origin and genetic
variation observed with other molecular typing methods
[23]. However, whether this genetic polymorphism of
H7 does or does not exist in ExPEC pathotypes is currently
unknown. Future studies focused on H7 allelic poly-
morphism of ExPEC may provide useful information to
develop a novel subtyping technique to distinguish differ-
ent ExPEC pathovars. The heterogeneity observed with
PFGE was even greater than serotyping indicating that
PFGE is not useful in distinguishing NMEC strains from
HFEC.
Ability to form biofilms in different environmental con-
ditions facilitates bacterial survival on abiotic surfaces and
their resistance to antimicrobials and antiseptics [25, 26].
Given that biofilm formation is reported to assist in
bacterial survival, colonization, and protection from host
immune responses and antimicrobial agents, the ability to
produce biofilms may play an important role in NMEC
virulence [25–27]. Therefore, we compared the capacity
Table 3 Occurrence (%) of virulence genes between neonatal
meningitis E. coli (NMEC) and fecal E. coli (HFEC)
Gene NMEC HFEC Chi Square value p value
afa 9.43 0.00 7.446 0.0064
aslA 88.68 45.83 41.814 <0.0001
aufA 62.26 20.83 32.952 <0.0001
cnf 27.45 4.17 20.19 <0.0001
fimH 92.45 100.00 6.380 0.0115
hly 30.19 0.00 32.980 <0.0001
hlyD 35.85 0.00 45.995 <0.0001
ibeA 35.85 20.83 6.881 0.0087
ibeB 100.00 91.67 6.380 0.0115
iss 25.49 4.17 16.132 <0.0001
iucC 74.51 2.08 109.471 <0.0001
iutA 30.19 0.00 32.980 <0.0001
K1 75.47 0.00 116.821 <0.0001
kpsII 90.57 27.08 82.038 <0.0001
neuC 71.70 18.75 54.522 <0.0001
nlp1 100.00 97.92 0.505 0.4773
ompA 66.04 60.41 0.536 0.464
papC 3.77 0.00 2.296 0.129
papGII 31.37 2.08 25.833 <0.0001
papGIII 21.57 0.00 22.523 <0.0001
sat 49.02 0.00 62.279 <0.0001
sfa/foc 49.06 0.00 62.279 <0.0001
sitA 92.45 25.00 89.713 <0.0001
traJ 43.40 10.41 26.287 <0.0001
vat 76.47 18.75 32.829 <0.0001
p <0.05 reflects a statistical significance. Virulence genes that were more
prevalent in NMEC compared to HFEC are marked in bold
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for biofilm formation by NMEC and HFEC. There was no
significant difference in the ability of biofilm formation
between NMEC and HFEC isolates when they were grown
in M9 medium. However, when LB broth was used as the
medium, NMEC demonstrated approximately 39 %
increase in their ability to form biofilms. In consistent with
our observations, previous studies have demonstrated that
growth medium has an effect on biofilm formation by
pathogenic bacteria [28, 29] . Jackson et al. noted that cen-
tral carbon flux has a regulatory effect on the formation of
biofilms [28]. In particular, readily available glucose has a
negative regulatory effect on biofilm formation suggesting
that the ability to form biofilms is a survival strategy by
bacteria when the source of carbon is limited or complex
Table 4 Antibiotic susceptibility profiles of NMEC and HFEC. Number of isolates (stated as percentages) in NMEC and HFEC were
categorized as Sensitive (S), Intermediate (I) or Resistant (R) according to CLSI standards
Antibiotic NMEC HFEC
S I R S I R
Ampicillin 50.94 3.773585 45.28 64.58 4.167 31.25
Cefazolin 96.23 0 3.77 93.75 0 6.25
Cefepime 96.23 0 3.77 100 0 0
Cefotaxime 90.57 0 9.43 93.75 0 6.25
Cefoxitin 90.57 0 9.43 95.83 2.08 2.08
Cefpodoxime 90.57 0 9.43 9.16 0 8.33
Ceftazidime 90.57 0 9.43 93.75 0 6.25
Ceftriaxone 88.68 1 9.43 91.66 2.08 6.25
Cephalothin 100 0 0 100 0 1
Ciprofloxacin 100 0 0 100 0 0
Gentamicin 100 0 0 100 0 0
Imipenem 100 0 0 100 0 0
Meropenem 100 0 0 100 0 0
Piperacillin/Tazobactam 100 0 0 100 0 0
Ceftazidime/Clavulanic acid 100 0 0 100 0 0
Amikacin 100 0 0 100 0 0
Amoxicillin 100 0 0 60.41 2.083 37.5
Chloramphenicol 94.34 0 5.66 97.91 2.083 0
Sulfa/Trimethoprim 81.13 0 18.86 93.75 0 6.25
Kanamycin 86.79 2 9.433 100 0 0
Nalidixic acid 96.23 0 3.773 81.25 0 18.75
Sulfisoxazole 67.92 3 14 68.75 16.66 14.58
Tetracycline 81.13 0 10 91.66 0 8.33
Table 5 Serotypes and multilocus sequence types (ST) of ESBL-positive isolates
Isolate Serotype Multilocus sequence alleles ST
adk fumC gyrB icd mdh purA recA
NMEC2 O75:H7 40 20 19 14 23 1 10 ST843
NMEC3 O2:H1 36 24 9 13 17 11 25 ST73
NMEC44 O78:H4 6 4 12 1 20 13 7 ST23
NMEC46 O1:H7 27 32 24 29 26 19 22 ST59
NMEC50 O18:H7 37 38 19 37 17 11 26 ST95
HFEC2 O137:H6/41 13 14 19 22 17 14 203 ST2678
HFEC9 O167:H7 6 4 5 18 8 14 Unknown ST
HFEC13a H7 6 19 3 16 11 8 173 Unknown ST
aNo agglutination with O antisera
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[28]. The M9 medium contained 2 % glucose which is a
readily available carbon source whereas in LB broth cata-
bolizable amino acids are the source carbon source for
bacterial growth. Increase in biofilm formation by NMEC
in LB broth as compared to M9 medium might be due to
readily available glucose in M9 medium suggesting that
the source of carbon has an effect on biofilm formation by
NMEC but not by HFEC.
Beta-lactam antibiotics are one of the major treatment
options available for controlling meningitis in infant
patients [30]. We evaluated the antibiotic sensitivity profiles
of NMEC and HFEC along with ESBL resistance profiles.
Although the majority of strains were sensitive to most of
the antibiotics tested, eight isolates showed an ESBL-
resistance phenotype. Interestingly, three of the ESBL-
resistant isolates were fecal commensal isolates implying
fecal flora as a source for the emergence of ESBL-resistance.
Previous studies have indicated an association between
ESBL types and MLST types [31]. The ESBL-positive E.
coli identified in this study fell into ST73, ST23, and
ST59 MLST types, which are known to contain E. coli
possessing certain ESBL types. However, none of the
ESBL-positive E. coli detected here did belong to ST131, a
major MLST type associated with ESBL-positive E. coli
[31]. The ESBL genes are commonly located on mobilizable
elements (e g. transposons and broad host range plasmids)
and ESBL genes are distributed among commensal micro-
flora of humans and animals [32]. Although a positive cor-
relation between the presence of ESBL-positive HFEC and
ESBL-positive UPEC has been observed by many investiga-
tors, there is no evidence to suggest an association between
the presence of ESBL-producing bacteria in vaginal or
fecal flora of pregnant women and corresponding ESBL-
producing bacterial infections in neonates [33]. Neverthe-
less, it has been demonstrated that the risk factors, such
as premature delivery, premature membrane rupture, and
low birth weight which are known to predispose infants to
E. coli meningitis were correlated with the colonization of
ESBL-producing Enterobacteriaceae in the infant gut [33].
Genetic heterogeneity of NMEC pathotype is one of
the major constraints posing today to understand the
pathogenesis of neonatal meningitis [7, 10, 12]. Con-
cordance with these previous studies, we have also ob-
served marked heterogeneity in the virulence gene profiles
of NMEC. Although NMEC possessed more virulence
genes than HFEC, some of the virulence genes (ibeA, sfa/
foc, traJ, and cnf1), which have previously been implicated
Fig. 3 Relative invasion frequencies observed between NMEC and HFEC
populations. **Denotes a statistically significant difference (p< 0.05)
Fig. 4 Distributin of K1, sitA, vat, neuC, and iucC genes among NMEC strains (n = 53). Red, positive for a gene; Grey, negative for a gene. Encircled
area indicates the isolates used to define a typical NMEC
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in NMEC pathogenesis were present only in <50 % of
NMEC examined (Fig. 2) [34–36]. The virulence traits,
such as fimH, ompA, and nlp1 that are considered to be
essential for NMEC survival in blood and the penetra-
tion of BBB were prevalent in both NMEC and HFEC
suggesting these genes do not define the NMEC patho-
type [34–39]. The NMEC and HFEC strains that did
not harbor these “essential” virulence genes were still
able to invade hCMEC/D3. These data indicate that
NMEC pathogenicity is poorly understood and high-
light the need for future research directed at mining
novel virulence traits that are truly involved in the
penetration of BBB.
In the present study, NMEC strains harbored genes
that encode iron acquisition systems (iutA, iucC, and
sitA) and hemolysins (hlyA and hlyD), which were
more frequently present in NMEC than in HFEC. In
addition to providing a source of iron for bacterial
growth through cell lysis, bacterial hemolysins are
known to play some other mechanistic roles as
well [40]. For example, sublytic amounts of E. coli he-
molysin have been shown to increase the permeability
of endothelial cell monolayers in a time- and dose-
dependent manner in cultured pulmonary artery
endothelial cells [40] . In the same study, a low dose
of hemolysin was found to induce a toxin-mediated
loss of endothelial barrier function. However, there is
no scientific evidence to support the involvement of
hemolysins of NMEC in increasing the permeability
of BBB thereby aiding the disease pathogenesis.
In this study, an in vitro invasion assay was conducted
to correlate the virulence traits of each isolate of E. coli
with its ability to penetrate the BBB. As expected, NMEC
strains which carried more virulence genes than HFEC
were also more invasive in hCMEC/D3 cells than HFEC
(Fig. 3). Interestingly, ten isolates of HFEC which demon-
strated a noninvasive phenotype with in vitro cell invasion
assay were negative for K1 capsular type, ibeA, traJ, and
sfa/foc but were positive for fimH, ibeB, and nlpl indicating
that ibeA, traJ, and sfa/foc may be important in NMEC
pathogenesis even though their occurrence in NMEC was
less than some other virulence genes. Except these ten
noninvasive isolates, all other HFEC were able to invade
the BBB barrier in vitro suggesting fecal commensal E. coli
as a potential source of NMEC. It is known that a high level
of bacteremia is a prerequisite for the attachment and inva-
sion of BBB by NMEC [9, 41]. The present study also dem-
onstrated that NMEC and HFEC were equally able to
survive in human serum, supporting the speculation
that commensal E. coli in the mother’s gut could be a
source for NMEC in the baby. Perhaps serum resistance
of NMEC may not be as important as previously
thought because neonatal serum is deficient in many
complement factors. It would be worthy to compare
the survival potential of NMEC in serum collected from
healthy adults and neonates. Further investigations on
HFEC strains exhibiting invasive properties using animal
models of meningitis may be needed to confirm that HFEC
indeed have the potential to cause neonatal meningitis.
Conclusions
The current study results indicate that regardless of the
genotypic and phenotypic heterogeneity observed among
NMEC strains, some genotypic characteristics can still
be used to distinguish NMEC from commensal E. coli.
Materials and methods
Bacterial strains and media
The NMEC comprised of 51 strains isolated from the
cerebrospinal fluid of neonates with meningitis plus two
well-characterized NMEC strains, RS218 (O18:K1:H7) and
EC10 (O7: K1). The RS218 [42] and EC10 [43, 44] strains
isolated from the cerebrospinal fluid of neonates with
meningitis in the 1970’s were kindly provided by Dr. James
Johnson, University of Minnesota, St. Paul, MN, USA and
Dr. David Klumpp, Northwestern University, Evanston, IL,
USA, respectively. Other NMEC strains (n = 51) isolated
between 1989 and 1997 from patients in the United States
were provided by Dr. K. S. Kim, Johns Hopkins Univer-
sity School of Medicine, Baltimore, Maryland, USA
[10, 42]. Fecal E. coli (n = 48) isolated from feces of
healthy individuals (HFEC) were obtained from the E. coli
Reference Center collection (Pennsylvania State Univer-
sity, University, Park, PA, USA). These isolates were col-
lected during the period between 1985 and 2005 from
healthy individuals in two states of the U.S., New York
and Pennsylvania. Unless otherwise mentioned, all the
bacterial strains were grown in Luria Bertani (LB) broth
(BD Technologies, Research Triangle Park, NC, USA) or
LB agar (BD Technologies).
Phylogrouping of E. coli
All strains were assigned to four main phylogenetic groups;
A, B1, B2 and D according to the method described by
Clemont et al. [17]. Classification of phylogenetic groups
was based on the amplification of two genes, chuA and
Table 6 Number of virulence traits present in neonatal
meningitis E. coli (NMEC) and fecal E. coli (HFEC) belonging to
different phylogroups
Phylogroup No. Virulence associated traits (Mean ± SD) p value
NMEC HFEC
A 10 ± 2.74 5.13 ± 2.33 0.0011a
B1 8.0 ± 2.83 6.5 ± 3.02 0.5610
B2 15.19 ± 3.21 4.64 ± 1.95 <0.0001a
D 12.4 ± 3.92 6.38 ± 2.79 0.0003a
aDenotes a statistically significant difference between NMEC and HFEC
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Table 7 Primers used in the study
Primer Name Gene/Function Sequence 5’–3’ Product size Reference
chuA.1 Phylogrouping GACGAACCAACGGTCAGGAT 279 [17]
chuA.2 TGCCGCCAGTACCAAAGACA
yjaA.1 Phylogrouping TGAAGTGTCAGGAGACGCTG 211 [17]
yjaA.2 ATGGAGAATGCGTTCCTCAAC
TspE4C2.1 Phylogrouping GAGTAATGTCGGGGCATTCA 152 [17]
TspE4C2.2 CGCGCCAACAAAGTATTACG
afaF Afimbrial adhesin CAT CAA GCT GTT TGT TCG TCC GCC G 750 [52]
afaR GCT GGG CAG CAA ACT GAT AAC TCT C
aslAF Arylsulfatase GCG TGA TGT TCA TGT CAA CC 463 [44]
aslAR ATC CGC CAG ATC TAC AAT GC
aufAF Auf fimbriae TGC ACA TCA GGA AAC CAG ATA C 350 This study
aufR GGC TCA CTG ATA TGG ATG ACA A
cnfF Cytotoxic necrotizing factor1 CAT TCA GAG TCC TGC CCT CAT TAT T 498 [53]
cnfR AAG ATG GAG TTT CCT ATG CAG GAG
fimHF Type I fimbriae GCA GTC ACC TGC CCT CCG GTA 508 [53]
fimHR TGC AGA ACG GAT AAG CCG TGG
hlyAF Alpha hemolysin ACC ATA TAA GCG GTC ATT CCC GTC A 1177 [53]
hlyAR AAC AAG GAT AAG CAC TGT TCT GGC T
hlyDF Secretion protein for HlyA CTC CGG TAC GTG AAA AGG AC 904 [54]
hlyDR GCC CTG ATT ACT GAA GCC TG
ibeAF Invasin of brain endothelium A CAT TAG CTC TCG GTT CAC GCT 171 [55]
ibeAR TTA CCG CCG TTG ATG TTA TCA
ibeBF Invasin of brain endothelium B GCA TATTCTGCTGGTTTCTAATGTC 660 This study
ibeBR GTT CTG GAT TTT CTG TTC ATA ATT CA
issF Increased serum survival CAG CAA CCC GAA CCA CTT GAT G 323 [54]
issR AGC ATT GCC AGA GCG GCA GAA
iutAF Aerobactin synthesis ATGAGCATATCTCCGGACG 587 [52]
iutAR CAGGTCGAAGAACATCTGG
iucCF Aerobactin synthesis ACC CGT CTG CAA ATC ATG GAT 269 [55]
iucCR AAA CCT GGC TTA CGC AAC TGT
sitAF Periplasmic iron-binding protein AGG GGG CAC AAC TGA TTC TCG 608 [56]
sitAR TAC CGG GCC GTT TTC TGT GC
kpsMTII F Capsular type II GCG CAT TTG CTG ATA CTG TTG 272 [57]
kpsMT IIR CAT CCA GAC GAT AAG CAT GAG CA
kpsMT K1 K 1 capsule TAG CAA ACG TTC TAT TGG TGC 153 [57]
kpsMT IIR CAT CCA GAC GAT AAG CAT GAG CA [57]
neuCF Capsular N-acetylneuraminic acid synthesis GGT GGT ACA TTC CGG GAT GTC 676 [52]
neuCR AGG TGA AAA GCC TGG TAG TGT G
Nlp I F New lipoprotein I (adhesin/invasin) AGT AAT ACT TCC TGG CGT AAA AGT GA 662 This study
Nlp I R AAA TAG AAG TTG GTT TCA CTG AGA TG
ompAF Outer membrane protein A CACTAAATCCAACGTTTATGGTAAAA This study
ompAR GATACCTTTAACTTCGATCTCTACGC
papCF Outer membrane usher protein of P pili ATA TCC TTT CTG CAG GGA TGC AAT A 205 [57]
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yjaA and the DNA fragment, TspE4C2 by using a multiplex
polymerase chain reaction (PCR) assay. The primers used
are listed in Table 7.
Serotyping
Serotyping was performed at the E. coli Reference Center
(Pennsylvania State University) using a standard serum
agglutination assay for the presence of all designated O
groups (O1 to O187 except O13, O22, O31, O47 and O94
that are not designated) and H types (H1 to H56) [45].
Serum resistance
Survival of bacterial strains (both NMEC and HFEC) in
normal human serum (EMD Millipore Corporation, Te-
mecula, CA, USA) was determined by colorimetric micro-
assay as previously described [46]. Briefly, log phase
cultures of bacterial strains were incubated for 3 h at 42 °C
in Peptone/Glucose broth containing 0.75 % bromothymol
blue with or without 20 % normal human serum (NHS).
Serum resistance of each strain was determined by compar-
ing the color change from green to yellow in the presence
of NHS.
Virulence typing of E. coli
NMEC and HFEC strains were examined for the pres-
ence of 26 genes encoding virulence factors (VFs) that
have been previously attributed to the establishment of
meningitis in neonates [1, 9]. The VFs included adhesins,
invasins, toxins, siderophores, and structural components
of E. coli. Virulence genes were detected by PCR amplifi-
cation carried out on a Master Cycler Pro (Eppendorf,
Hamburg, Germany). All primers were obtained from In-
tegrated DNA Technologies (Coralville, IA, USA) and are
listed in Table 7. Crude DNA was extracted by a rapid
Table 7 Primers used in the study (Continued)
papCR GAC GGC TGT ACT GCA GGG TGT GGC G
papG IF Fimbrial adhesin PapG allele I CTA CTA TAG TTC ATG CTC AGG TC 474 [54]
papG IR CCT GCA TCC TCC ACC ATT ATC GA
papG IIF Fimbrial adhesin PapG allele II CCC AGC TTT GTT ATT TTC CTT G 190 [54]
papGIIR TTC TTA CCA TGG CTG TAT GTC G
papGIIIF Fimbrial adhesin PapG allele III GGC CTG CAA TGG ATT TAC CTG G 258 [54]
papGIIIR CCA CCA AAT GAC CAT GCC AGA C
satF Secreted autotransporter toxin GCAGCAAATATTGATATATCA 630 [58]
satR GTTGTTGACCTCAGCAAGGAA
sfa/focF S fimbrial adhesin CGG AGG AGT AAT TAC AAA CCT GGC A 410 [57]
sfa/focR CTC CGG AGA ACT GGG TGC ATC TTA C
trajF Conjugal transfer CAA TGG GGC TTT TAT TGA ACT C 369 This study
trajR TGA CCA ACA CCC AGC ATA TAA A
vat1 Vacuolating cytotoxin TCC TGG GAC ATA ATG GTC AG 900 This study
vat2 GTG TCA GAA CGG AAT TGT
adkF MLST ATTCTGCTTGGCGCTCCGGG 583 [49]
adkR CCGTCAACTTTCGCGTATTT
fumCF MLST TCACAGGTCGCCAGCGCTTC 806 [49]
fumR GTACGCAGCGAAAAAGATT
gyrBF MLST TCGGCGACACGGATGACGGC 911 [49]
gyrBR GTCCATGTAGGCGTTCAGGG
icdF MLST ATGGAAAGTAAAGTAGTTGTTCCGGCACA 878 [49]
icdR GGACGCAGCAGGATCTGTT
mdhF MLST ATGAAAGTCGCAGTCCTCGGCGCTGCTGGCGG 932 [49]
mdhR TTAACGAACTCCTGCCCCAGAGCGATATCTTTCTT
purAF MLST TCGGTAACGGTGTTGTGCTG 816 [49]
purAR CATACGGTAAGCCACGCAGA
recAF MLST CGCATTCGCTTTACCCTGACC 780 [49]
recAR TCGTCGAAATCTACGGACCGGA
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boiling method [47]. All PCRs were performed in 25-μl re-
actions containing 1 U of Taq DNA polymerase (Denville
Scientific Inc., Metuchen, NJ, USA), 25 pmol each of the
forward and reverse primers, and 5 nmol of each deoxy-
nucleoside triphosphate (Denville) in 1× buffer (15 mM
MgCl2, 100 mM KCl, 80 mM (NH4)2SO4, 100 mM
Tris–HCl, pH 9.0, 0.5 % NP-40). The cycling conditions
were as follows: initial denaturation at 94 °C for 3 min,
followed by 30 cycles of three steps consisting denatur-
ation at 94 °C for 1 min, primer annealing at the tem-
peratures indicated in Table 7 for 1 min, and extension
at 72 °C for at least 30 s, according to the size of the amp-
lified fragment (1 min/Kbp), and followed by a final exten-
sion at 72 °C for 10 min. Products were electrophoresed
in a 1.5 % agarose gel (Denville) for 1 h at 120 V, stained
with ethidium bromide (Bio-Rad Laboratories, Hercules,
CA, USA), and photographed under UV light using a gel
documentation system (AlphaImager® HP, Alpha Innotech
Corporation, San Leandro, CA, USA). Each PCR included
a negative control that contained all reagents except tem-
plate DNA and a positive control that contained an E. coli
that is known to carry the respective virulence gene.
Pulsed-field gel electrophoresis
PFGE was conducted according to the method
described by PulseNet [48]. Chromosomal DNA was
digested with the XbaI restriction enzyme. The electro-
phoresis was performed using a CHEF DRII system
(Bio-Rad, Marnes-la-Coquette, France) and the condi-
tions consisted of an initial time of 2.2 s, a final time
of 54.2 s at a gradient of 6 V cm−1 and an included
angle of 120°. The gels were electrophoresed for 24 h.
Salmonella enterica serotype Braenderup strain H9812
(ATCC BAA664, Manassas, VA, USA) was used as a mo-
lecular weight standard. A dendrogram was constructed
using the Dice similarity coefficient and the unweighted-
pair group method by average linkages (UPGMA) or
neighbor joining algorithm with 3 % position tolerance
using Bionumerics 4.0 software (Applied Maths, Austin,
Texas, USA).
Biofilm assay
Qualitative biofilm assay was performed following the
procedure described previously [27]. Briefly, overnight
bacterial cultures were diluted to 1:100 in M9 minimal
medium (BD Technologies) containing 10 μg/ml niacin
or LB medium followed by inoculation into U-bottom
96-well plates (Denville) in triplicates. The plates were
incubated at room temperature for 24 h at 37 °C. The
plates were washed three times with distilled water and
biofilms were stained with 0.1 % crystal violet for 15 min.
After three washes with distilled water, the presences or
absence of biofilms was evaluated.
Antibiotic susceptibility testing
Kirby-Bauer (KB) disk diffusion assay was conducted to
determine antibiotic resistance profiles using antibiotic
paper disks (BD Technologies). The antibiotics used in
KB test were amikacin (30 μg), amoxicillin with clavula-
nic acid (20/10 μg), chloramphenicol (30 μg), kanamycin
(30 μg), nalidixic acid (30 μg), sulfamethoxazole with tri-
methoprim (23.75/1.25 μg), sulfisoxazole (0.25 μg), and
tetracycline (30 μg). Susceptibility or resistance profiles
were interpreted according to Clinical Laboratory Stan-
dards Institute (CLSI) guidelines. Extended spectrum
β-lactamase (ESBL) sensitivity profiles were screened
using confirmatory ESBL plates according to manufac-
turer’s instructions (Sensititre; Thermo Fisher Scien-
tific, Oakwood Village, OH, USA). The dilution range
of antibiotic concentrations used were as follows; cefa-
zolin (8–16 μg/ml), cefepime (1–16 μg/ml), cefoxitin
(4–64 μg/ml), meropenem (1–8 μg/ml), cephalothin
(8–16 μg/ml), cefpodoxime (0.5–64 μg/ml), ceftriaxone
(1–128 μg/ml), ciprofloxacin (1–2 μg/ml), gentamicin
(4–16 μg/ml), ampicillin (8–16 μg/ml), imipenem (0.5–
16 μg/ml), piperacillin/tazobactam (4/4–64/4 μg/ml),
ceftazidime (0.25–128 μg/ml), ceftazidime/clavulanic
Acid (0.25/4–128/4 l μg/ml) and cefotaxime (0.25–
64 μg/ml). Plates were incubated at 37 °C for 18 h and
read automatically using Sensititre System (Thermo
Fisher Scientific).
Multilocus sequence typing
Multilocus sequence typing (MLST) of ESBL-positive
E. coli isolates was performed using seven housekeep-
ing genes (adk, fumC, gyrB, icd, mdh, purA, and
recA), as described previously [49]. Primer sequences
were obtained from the E. coli MLST database web-
site (http://mlst.ucc.ie/mlst/dbs/Ecoli) (Table 7). The
cycling conditions were as follows: initial denaturation
at 95 °C for 5 min, followed by 30 cycles of initial de-
naturation at 95 °C for 30 s, primer annealing at the
melting temperatures for 30 s, and extension at 72 °C
1 min and followed by a final extension at 72 °C for
10 min. The PCR products were treated with exo-
nuclease I and shrimp alkaline phosphatase (Affyme-
trix, Santa Clara, CA, USA) and sequenced at the
Genomics Core Facility (Penn State University) with
the same primers used to generate PCR products. Se-
quences were compared with E. coli MLST database
website to determine the MLST types.
In-vitro cell invasion assay
The hCMEC/D3 cell line, which is known to possess the
main characteristics of primary brain endothelial cells,
was kindly provided by Dr. Babette Weksler at Weill
Cornell Medical College (New York, NY, USA) [50]. In-
vasion assays were performed in triplicates using the
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method described previously [51]. Briefly, hCMEC/D3
cells were seeded on 96-well tissue culture plates coated
with rat collagen (R&D Systems, Inc., Minneapolis, MN,
USA) and maintained at 37 °C for six days in a humidi-
fied chamber containing 5 % CO2 to form a confluent
monolayer. The complete medium used for culturing of
hCMEC/D3 cells was EBM-2 endothelial basal medium
(Lonza, Allendale, NJ, USA) containing 5 % bovine serum
(GE Healthcare Bio-Sciences, Pittsburgh, PA, USA),
1.4 μM hydrocortisone (Sigma-Aldrich, St. Louis, MO,
USA), 5 μg/ml ascorbic acid (Sigma), 1 % chemically de-
fined lipid concentrate (Invitrogen, Carlsbad, CA, USA),
10 mM HEPES (GE Healthcare Bio-Sciences), and 1 ng/ml
human basic fibroblast growth factor (Sigma). Cells were
infected with E. coli strains with a multiplicity of infection
(MOI) of 100 (100 bacteria per hCMEC/D3) and incubated
for 2 hours at 37 °C in 5 % CO2. Cells were then washed
with phosphate-buffered saline (PBS, pH 7) three times
and incubated with fresh complete EBM-2 medium con-
taining 100 μg/ ml gentamicin (Sigma) for one hour to kill
extracellular bacteria. Subsequently, 0.2 ml of 0.01 % Tri-
ton X-100 (Sigma) was added to each well to release intra-
cellular bacteria. Cells were fully disrupted by repeated
pipetting and viable bacteria were enumerated by plating
onto LB agar. Invasion frequencies were calculated com-
paring the ratio between the number of colony forming
units (CFU) released from the cells and the number of
CFU inoculated per well. To standardize the comparison
of invasion frequencies, relative invasion was calcu-
lated as a percent of invasion in comparison to the
well-characterized NMEC strain RS218, which was
arbitrarily set at 100 %.
Ethics statement
Both NMEC and HFEC isolates, in their entirety, were
collected for purposes other than this study and were
given without any Health Insurance Portability and
Accountability Act (HIPAA) identifiers by Dr. K.S. Kim
(Johns Hopkins University, Baltimore, MD, USA) and
Dr. C. DebRoy (E. coli Reference Center, University
Park, PA, USA).
Statistical analysis
Data were statistically analyzed by Fisher’s exact test (viru-
lence genotyping and phylogrouping), two-tailed student’s
t -test (invasion frequency), and a p < 0.05 was considered
statistically significant. The heat map of virulence gene
profiles was constructed using the R code (version 3.1.1).
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